Neurogene Inc.
NGNE
$20.02
$0.784.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 925.00K | 925.00K | 925.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 925.00K | 925.00K | 925.00K |
| Cost of Revenue | 69.71M | 68.76M | 65.14M | 60.83M | 57.66M |
| Gross Profit | -69.71M | -68.76M | -64.21M | -59.90M | -56.74M |
| SG&A Expenses | 27.60M | 26.93M | 25.53M | 22.61M | 19.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.31M | 95.69M | 90.67M | 83.44M | 76.66M |
| Operating Income | -97.31M | -95.69M | -89.75M | -82.51M | -75.74M |
| Income Before Tax | -85.13M | -84.39M | -80.87M | -75.14M | -53.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -85.13 | -84.39 | -80.87 | -75.14 | -53.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -85.13M | -84.39M | -80.87M | -75.14M | -53.25M |
| EBIT | -97.31M | -95.69M | -89.75M | -82.51M | -75.74M |
| EBITDA | -94.21M | -92.56M | -86.56M | -79.27M | -72.46M |
| EPS Basic | -4.12 | -4.32 | -4.36 | -4.29 | 78.14 |
| Normalized Basic EPS | -2.57 | -2.70 | -2.73 | -2.68 | -15.63 |
| EPS Diluted | -4.12 | -4.32 | -4.37 | -4.29 | -0.26 |
| Normalized Diluted EPS | -2.57 | -2.70 | -2.73 | -2.68 | -2.55 |
| Average Basic Shares Outstanding | 82.69M | 78.47M | 74.36M | 70.27M | 51.44M |
| Average Diluted Shares Outstanding | 82.69M | 78.47M | 74.36M | 70.27M | 68.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |